Optinose (OPTN) PT Lowered to $1 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Optinose (NASDAQ: OPTN) to $1.00 (from $3.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
